Page 27 - Eua News Today : Breaking News, Live Updates & Top Stories | Vimarsana

It achieves the level of antibodies we would expect so it really is, as you point out, yasmin, that 2 to 4-year age range. that's a very important one as we've talked about so i think that what's happened since then is one. omicron. we've had an incredible surge, which has resulted in some of the highest numbers of cases in children under the age of 5, particularly hospitalized children. and i just want to kind of highlight this fact. some people say, well, not that many children get hospitalized. yes, that's true, compared to who? adults. but why should we accept any hospitalization if it can...

Regimen while continuing to test three doses in the same age group. federal regulators hope it will be granted by the end of this month. let's start with this question. i wrote this down to make sure i got it right here. when pfizer released their findings in december, they found in children 6 months to 2 years, just a tenth of the adult dose created immune responses to those 16 to 25. not as strong in kids 2 to 4. that's why they are testing a third dose. they don't have the results from that. they will apply for this eua any way. should they wait for those or do you support that application ...

They will vaccinate their young ones against the virus as soon as possible. with me now to discuss is dr. kavita patel, msnbc medical contributor and former white house policy director under the obama administration. dr. patel, it's great to see you as always. thanks for joining us on this. so. when i saw this come through, we talked about this so many times, we both have young kids, i thought, yay, amazing, but then i paused and thought about the timing of all this because one of the reasons why essentially this process was put on hold around christmas or so was because there wasn't enough ev...

Complete confidence that this is safe and effective? >> i believe that if the fda grants an eua for it, that they will demand that data. now, which suggests to me that perhaps pfizer has some data that they have not yet released that would support a two-dose approval strategy. but they haven't released that to the public yet, particularly for the 2 to 4-year-old group. >> we'll be watching carefully on that. thank you so much, dr. jonathan reiner, it's good to see you. >> my pleasure. across the country there is a wave of bomb threats targeting several hbcus. the latest on this string of thr...

Been, they are covered been an eua for two shots. will they need a booster at five months like older populations? >> if i had to guess, i would think probably but once again, wait and see. that's why we do the trials in order to get the data, evaluate them carefully so we can make very solid recommendations out there. certainly, children 5 and older are eligible for vaccine and goodness, we haven't vaccinated nearly enough of them yet. we still have a large job to do there. >> okay. thank you for helping us understand what may be on the horizon. great to talk to you. >> thank you, doctor. th...